4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Market Cap $1.561B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| SIQ | Ann: Goldman Sachs Small & Mid-Cap Conference Presentation | 17/04/18 | 0 | 88 | |||
|
|||||||
| SIQ | Ann: Change in substantial holding | 16/04/18 | 0 | 74 | |||
|
|||||||
| SIQ | Ann: Change of Director's Interest Notice | 11/04/18 | 1 | 179 | |||
|
|||||||
| SIQ | Ann: Appendix 3B - issue under Share Purchase Plan | 06/04/18 | 0 | 74 | |||
|
|||||||
| SIQ | Ann: Close of Share Purchase Plan and Issue Price | 05/04/18 | 0 | 61 | |||
|
|||||||
| SIQ | Ann: Appendix 3B - issue under employee share plan | 28/03/18 | 0 | 82 | |||
|
|||||||
| SIQ | Ann: Notice of Annual General Meeting/Proxy Form | 28/03/18 | 0 | 78 | |||
|
|||||||
| SIQ | Ann: Ceasing to be a substantial holder | 19/03/18 | 0 | 104 | |||
|
|||||||
See All Discussions
ASX News